Baltussen R M, Wielink G, Stoevelaar H J, Van der Wilt G J, Severens J L, Ament A J
Department of Health, Organisation, Policy, and Economics, Maastricht University, P.O. Box 616, NL-6200 MD Maastricht, The Netherlands.
World J Urol. 1998;16(2):142-7. doi: 10.1007/s003450050041.
The goal of this study was to assess the economic impact of introducing transurethral microwave thermotherapy (TUMT) in the treatment of benign prostatic hyperplasia (BPH). Different scenarios were constructed using both randomized clinical trial data and observational data on resource use related to BPH treatments. These include a baseline scenario, demand scenarios reflecting the number of men who will be treated by TUMT when it is introduced, and supply scenarios reflecting the number of hospitals that will provide TUMT. In the baseline scenario, costs of BPH treatment equal Netherlands guilders (NLG) 203 million. If the demand for BPH treatment does not increase following the adoption of TUMT, costs may vary between NLG 187 and 189 million, depending on how TUMT is provided. If the demand increases up to 25% following the introduction of TUMT, costs may vary between NLG 457 and 466 million, depending on how TUMT is provided. The introduction of TUMT seems to be cost-saving, but savings depend on the number of men who seek treatment for BPH. There is no indication for a controlled provision.
本研究的目的是评估引入经尿道微波热疗（TUMT）治疗良性前列腺增生（BPH）的经济影响。利用随机临床试验数据和与BPH治疗相关的资源使用观察数据构建了不同的情景。这些情景包括一个基线情景、反映引入TUMT后将接受治疗的男性人数的需求情景，以及反映将提供TUMT的医院数量的供应情景。在基线情景中，BPH治疗成本为2.03亿荷兰盾。如果采用TUMT后BPH治疗需求没有增加，成本可能在1.87亿至1.89亿荷兰盾之间，具体取决于TUMT的提供方式。如果引入TUMT后需求增加25%，成本可能在4.57亿至4.66亿荷兰盾之间，具体取决于TUMT的提供方式。引入TUMT似乎可以节省成本，但节省的成本取决于寻求BPH治疗的男性人数。没有迹象表明需要进行控制性供应。
